EUVIMEDEUVIMED entdecken
Übersichtsarbeit

mTOR inhibitors potentially preserve fertility in female patients with haematopoietic malignancies: a narrative review

Yuji Tanaka iD, Tsukuru Amano iD, Akiko Nakamura iD, Mari Deguchi iD, Akimasa Takahashi iD, Shunichiro Tsuji iD, Takashi Murakami iD

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-06090-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Hematology, 2024. Verfasst von Yuji Tanaka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shiga University of Medical Science, 520-2192/Seta Tsukinowa-cho, Otsu, Shiga, Japan. yujit@belle.shiga-med.…. Hauptthemen laut MEDLINE: Fertility Preservation, Hematologic Neoplasms, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Haematologic malignancies are considered among the more common adolescent and young adult (AYA) cancers. Many female AYA patients with haematopoietic malignancies face impaired fertility. Haematologic malignancies patients tend to be treated with more aggressive systemic chemotherapy than that of solid tumours. In adult women, treatment-related contraception causes age-related fertility loss. Graft-versus-host disease (GVHD) after allogeneic haematopoietic stem cell transplantation is associated with decreased fertility. Ovarian cryopreservation is often indicated for haematopoietic malignancies; however, follicle loss associated with ovarian cryopreservation and ovarian minimal residual disease, which result in the withdrawal of the transplantation, are important issues. These problems may not be fully addressed by conventional methods of fertility preservation, such as oocyte, embryo, and ovarian cryopreservation, leaving room for research into new treatment approaches, such as fertility preservation drugs. In recent years, preclinical studies have shown that mTOR inhibitors may preserve chemotherapy-induced follicular loss, may have follicle-preserving effects on follicle loss associated with cryopreservation and transplantation of ovarian tissue, may have fertility-preserving effects on aging-related infertility. Clinical studies have shown that mTOR inhibitors may have the potential for indirect fertility preservation by controlling GVHD, have a limited anti-tumor effect against haematopoietic malignancies. The purpose of this article is to outline the various issues faced by female survivors of haematopoietic malignancies and discuss the potential of mTOR inhibitors as a safe treatment option. Based on current research, mTOR inhibitors seem promising and innovative fertility preservation agents regarding preclinical conditions, and further study, including clinical trials, should be expected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationHematologic NeoplasmsTOR Serine-Threonine KinasesHumansFemaleHematopoietic Stem Cell TransplantationInfertility, FemaleAdultCryopreservationOvaryAdolescentGraft vs Host DiseaseYoung AdultAntineoplastic Agents

Stichwörter der Autor:innen

Fertility preservationHaematopoietic malignancyInfertilityMalignant lymphomaRapamycinmTOR inhibitor

Substanzen

TOR Serine-Threonine KinasesMTOR protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shiga University of Medical Science, 520-2192/Seta Tsukinowa-cho, Otsu, Shiga, Japan. yujit@belle.shiga-med.ac.jp.
  • Department of Obstetrics and Gynecology, Shiga University of Medical Science, 520-2192/Seta Tsukinowa-cho, Otsu, Shiga, Japan.

ORCID-Profile: Yuji Tanaka, Tsukuru Amano, Akiko Nakamura, Mari Deguchi, Akimasa Takahashi, Shunichiro Tsuji, Takashi Murakami

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Tanaka, Y., Amano, T., Nakamura, A., Deguchi, M., Takahashi, A., Tsuji, S., & Murakami, T. (2024). mTOR inhibitors potentially preserve fertility in female patients with haematopoietic malignancies: a narrative review. Annals of Hematology. https://doi.org/10.1007/s00277-024-06090-3

Vancouver

Tanaka Y, Amano T, Nakamura A, Deguchi M, Takahashi A, Tsuji S, et al. mTOR inhibitors potentially preserve fertility in female patients with haematopoietic malignancies: a narrative review. Annals of Hematology. 2024. doi:10.1007/s00277-024-06090-3

BibTeX
@article{Tanaka2024,
  author = {Tanaka, Yuji and Amano, Tsukuru and Nakamura, Akiko and Deguchi, Mari and Takahashi, Akimasa and Tsuji, Shunichiro and Murakami, Takashi},
  title = {mTOR inhibitors potentially preserve fertility in female patients with haematopoietic malignancies: a narrative review},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-06090-3}
}
Kostenlos starten →